The Scientist

» stress and disease/medicine

Most Recent

image: Cancer Test Gets Bad Reviews

Cancer Test Gets Bad Reviews

By | May 22, 2012

US Preventive Services Task Force recommends against a commonly used prostate cancer screening.

2 Comments

image: Passing On Stress

Passing On Stress

By | May 22, 2012

US Preventive Services Task Force recommends against a commonly used prostate cancer screening.

4 Comments

image: How Castor Oil Stimulates Labor

How Castor Oil Stimulates Labor

By | May 21, 2012

US Preventive Services Task Force recommends against a commonly used prostate cancer screening.

0 Comments

image: HIV Prevention Debate

HIV Prevention Debate

By | May 21, 2012

US Preventive Services Task Force recommends against a commonly used prostate cancer screening.

1 Comment

image: Gene Therapy for Brain Disease

Gene Therapy for Brain Disease

By | May 16, 2012

US Preventive Services Task Force recommends against a commonly used prostate cancer screening.

0 Comments

image: Does Education Boost Health?

Does Education Boost Health?

By | May 15, 2012

US Preventive Services Task Force recommends against a commonly used prostate cancer screening.

2 Comments

image: Bionic Eye Sees the Light

Bionic Eye Sees the Light

By | May 15, 2012

US Preventive Services Task Force recommends against a commonly used prostate cancer screening.

0 Comments

image: Opinion: Misleading Drug Trials

Opinion: Misleading Drug Trials

By | May 14, 2012

US Preventive Services Task Force recommends against a commonly used prostate cancer screening.

23 Comments

image: New Algerian Research Center

New Algerian Research Center

By | May 14, 2012

US Preventive Services Task Force recommends against a commonly used prostate cancer screening.

2 Comments

image: Approving

Approving

By | May 14, 2012

US Preventive Services Task Force recommends against a commonly used prostate cancer screening.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech